HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

50.500

-3.400-6.31%

Volume:24.30M

Turnover:1.23B

Market Cap:29.44B

PE:-11.27

High:53.350

Open:53.350

Low:49.000

Close:53.900

52wk High:80.900

52wk Low:29.980

Shares:583.00M

HK Float Shares:583.00M

Volume Ratio:1.41

T/O Rate:4.17%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-4.480

ROE:--

ROA:-1.36%

PB:6.86

PE(LYR):-11.27

PS:27.78

Loading ...

Overview Company News Filings

Movement Alert｜INSILICO Drops 5.1% in Regular Trading, Trading at HK$51.35

Insilico Medicine Doses First Patient in Phase III Genesis-IPF-3 Trial of Rentosertib for IPF

Insilico Medicine Doses First Patient in Genesis-Ipf-3, the World's First Phase Iii Trial of a Generative AI-Driven Innovative Drug

THOMSON REUTERS

AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients

Insilico Medicine Marks Milestone as First Patient Dosed in Phase III Trial of AI-Discovered IPF Drug Rentosertib

Bulletin Express

花旗维持英矽智能买入评级，目标价85港元，看好衰老生物学平台潜力

Movement Alert｜INSILICO Rises 6% in Regular Trading, Core Pipeline Rentosertib Published in Nature Biotechnology Showcasing Anti-Aging Potential

Movement Alert｜INSILICO Rises 5.64% in Regular Trading, Strategic Partnership with MobiDrop to Co-Build AI-Ready Data Infrastructure

Insilico Study Says AI-Designed IPF Drug Rentosertib Reverses Biological Age on Six Proteomic Clocks

Insilico AI-Developed Drug Candidate Shows Anti-Aging Potential in New Study

AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets

INSILICO Adds 0.25 Million New Shares in August 2026, Keeps Public Float Above 15 %

Bulletin Express

InSilico Medicine Cayman TopCo: JPMorgan Chase & Co. Disposes of Shares, Long Position Falls to 5.83%

Hong Kong Stocks Rise on Easing Rate Fears; InSilico Medicine Gains 4%

MT Newswires Live

InSilico Medicine Chairman Earmarks HK$16 Million to Boost Shareholding

MT Newswires Live

InSilico Medicine Climbs as Chairman Plans to Buy Shares

Movement Alert｜INSILICO Rises 5.32% in Regular Trading, Chairman Launches Up to HK$16 Million Share Purchase Plan

Insilico Medicine Cayman Topco's Chairman Initiates Share Increasing Plan

Insilico Medicine: Chairman Plans Up to HKD16.00 Million Share Purchase in September 2026

Bulletin Express

INSILICO Chairman Plans Share Acquisition of Up to HK$16 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/03696/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"03696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"INSILICO","latestPrice":50.5,"timestamp":1789114135006,"preClose":53.9,"halted":0,"volume":24304761,"delay":0,"changeRate":-0.06307977736549163,"floatShares":583000000,"shares":583000000,"eps":-4.48,"marketStatus":"Market Closed","change":-3.4,"latestTime":"09-11 16:08:55","open":53.35,"high":53.35,"low":49,"amount":1226563139,"amplitude":0.080705,"askPrice":50.55,"askSize":112000,"bidPrice":50.5,"bidSize":1857000,"shortable":3,"etf":0,"ttmEps":-4.006,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":7,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":53.9,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":1.4101144088786064,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","floatShares":583000000,"roa":"-1.36%","roe":"--","lyrEps":-4.48,"volumeRatio":1.4101144088786064,"shares":583000000,"dividePrice":0,"high":53.35,"amplitude":0.080705,"preClose":53.9,"low":49,"week52Low":29.98,"pbRate":"6.86","psRate":"27.78","week52High":80.9,"institutionHeld":0,"latestPrice":50.5,"committee":0.886237,"eps":-4.48,"divideRate":0,"volume":24304761,"delay":0,"ttmEps":-4.006,"open":53.35,"prevYearClose":37.14,"prevWeekClose":48.76,"prevMonthClose":43.74,"prevQuarterClose":39.62,"fiveDayClose":48.76,"twentyDayClose":44.56,"sixtyDayClose":33.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03696\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-03-30","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1786032000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03696","date":"2026-09-11","current":-12.606091,"percent":0.511628,"low":-126.474328,"twenty":-92.779015,"median":-12.517861,"eighty":-8.825762,"high":-6.819055,"avg":-40.152843,"sd":41.414487,"marketCap":29079818091},"quantilePoints":[{"date":"2026-01-02","current":-60.518922,"twenty":-60.091977,"median":-54.070713,"eighty":-44.509914,"marketCap":20885577298},{"date":"2026-01-09","current":-75.603624,"twenty":-68.00457,"median":-60.518922,"eighty":-55.21804,"marketCap":26120865700},{"date":"2026-01-16","current":-88.730045,"twenty":-88.029114,"median":-68.708073,"eighty":-60.032461,"marketCap":30678123120},{"date":"2026-01-23","current":-103.197987,"twenty":-90.498742,"median":-83.671368,"eighty":-60.384368,"marketCap":35679909160},{"date":"2026-01-30","current":-103.586135,"twenty":-97.608242,"median":-87.528966,"eighty":-61.04227,"marketCap":35850899140},{"date":"2026-02-06","current":-102.242154,"twenty":-102.624487,"median":-88.730045,"eighty":-63.670801,"marketCap":35423424190},{"date":"2026-02-13","current":-120.862692,"twenty":-111.02361,"median":-93.674734,"eighty":-69.411577,"marketCap":41892545100},{"date":"2026-02-20","current":-120.573146,"twenty":-113.535701,"median":-95.532684,"eighty":-72.22559,"marketCap":41778551780},{"date":"2026-02-27","current":-101.790811,"twenty":-112.276672,"median":-99.165731,"eighty":-75.603624,"marketCap":35309430870},{"date":"2026-03-06","current":-91.269503,"twenty":-111.865913,"median":-96.698006,"eighty":-83.671368,"marketCap":31633146300},{"date":"2026-03-13","current":-90.695168,"twenty":-110.462075,"median":-97.855611,"eighty":-84.923636,"marketCap":31476674990},{"date":"2026-03-20","current":-90.217416,"twenty":-108.336494,"median":-95.132264,"eighty":-85.637602,"marketCap":31333988340},{"date":"2026-03-27","current":-94.081335,"twenty":-107.867915,"median":-93.382526,"eighty":-84.923636,"marketCap":32646705520},{"date":"2026-04-02","current":-11.868567,"twenty":-107.743793,"median":-93.151788,"eighty":-79.84609,"marketCap":32770014500},{"date":"2026-04-10","current":-12.877757,"twenty":-106.637664,"median":-92.691879,"eighty":-68.00457,"marketCap":35546164200},{"date":"2026-04-17","current":-12.624497,"twenty":-104.449464,"median":-91.076584,"eighty":-59.957423,"marketCap":34802041600},{"date":"2026-04-24","current":-14.676127,"twenty":-103.459526,"median":-89.747522,"eighty":-15.148699,"marketCap":40497441500},{"date":"2026-04-30","current":-13.071473,"twenty":-103.255287,"median":-88.68986,"eighty":-14.223075,"marketCap":36089946100},{"date":"2026-05-08","current":-13.340785,"twenty":-103.091175,"median":-88.574112,"eighty":-13.384736,"marketCap":36805448600},{"date":"2026-05-15","current":-10.983422,"twenty":-102.596106,"median":-86.723486,"eighty":-13.331626,"marketCap":30308685900},{"date":"2026-05-22","current":-10.451313,"twenty":-102.308283,"median":-85.637602,"eighty":-12.881328,"marketCap":28849060800},{"date":"2026-05-29","current":-8.622113,"twenty":-102.242154,"median":-83.671368,"eighty":-12.624497,"marketCap":23800475160},{"date":"2026-06-05","current":-7.875348,"twenty":-101.790811,"median":-78.255166,"eighty":-12.515704,"marketCap":21739827960},{"date":"2026-06-12","current":-7.01543,"twenty":-100.06892,"median":-65.190557,"eighty":-12.085532,"marketCap":19370083680},{"date":"2026-06-18","current":-7.947724,"twenty":-100.046598,"median":-60.518922,"eighty":-10.958896,"marketCap":21945892680},{"date":"2026-06-26","current":-7.919554,"twenty":-99.340788,"median":-54.070713,"eighty":-10.005367,"marketCap":21877204440},{"date":"2026-07-03","current":-7.743582,"twenty":-98.690073,"median":-27.191152,"eighty":-9.565807,"marketCap":21396386760},{"date":"2026-07-10","current":-8.877372,"twenty":-98.062553,"median":-14.676127,"eighty":-8.824583,"marketCap":24510253640},{"date":"2026-07-17","current":-8.953114,"twenty":-97.4013,"median":-14.167396,"eighty":-8.882012,"marketCap":24727766400},{"date":"2026-07-24","current":-9.751189,"twenty":-96.617922,"median":-13.560542,"eighty":-8.925911,"marketCap":26937238120},{"date":"2026-07-31","current":-9.466525,"twenty":-95.411086,"median":-13.340785,"eighty":-8.88656,"marketCap":26158771400},{"date":"2026-08-07","current":-9.410567,"twenty":-94.035578,"median":-13.201047,"eighty":-8.763781,"marketCap":26009946880},{"date":"2026-08-14","current":-9.225945,"twenty":-93.733176,"median":-12.895614,"eighty":-8.825762,"marketCap":25506233120},{"date":"2026-08-21","current":-8.414722,"twenty":-93.349385,"median":-12.788902,"eighty":-8.725669,"marketCap":23250969240},{"date":"2026-08-28","current":-11.42993,"twenty":-93.240519,"median":-12.603589,"eighty":-8.725669,"marketCap":26661298566},{"date":"2026-09-04","current":-12.035257,"twenty":-93.142096,"median":-12.516782,"eighty":-8.763781,"marketCap":28077860002},{"date":"2026-09-11","current":-12.463145,"twenty":-92.779015,"median":-12.517861,"eighty":-8.825762,"marketCap":29079818091}],"updateTime":1789284922524},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03696\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1190637599","title":"Movement Alert｜INSILICO Drops 5.1% in Regular Trading, Trading at HK$51.35","url":"https://stock-news.laohu8.com/highlight/detail?id=1190637599","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190637599?lang=en_us&edition=fundamental","pubTime":"2026-09-11 09:50","pubTimestamp":1789091436,"startTime":"0","endTime":"0","summary":"On September 11, INSILICO fell 5.1% in regular trading, trading at HK$51.35/share, with Turnover of HK$170 million.Within the Life Sciences Tools & Services sector where INSILICO belongs, individual...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666555013","title":"Insilico Medicine Doses First Patient in Phase III Genesis-IPF-3 Trial of Rentosertib for IPF","url":"https://stock-news.laohu8.com/highlight/detail?id=2666555013","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666555013?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:30","pubTimestamp":1789000222,"startTime":"0","endTime":"0","summary":"Insilico Medicine doses first patient in Phase III GENESIS-IPF-3 trial of rentosertib for IPFInsilico Medicine launched a Phase III study of rentosertib in idiopathic pulmonary fibrosis, dosing the fi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL3TZwy3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666550995","title":"Insilico Medicine Doses First Patient in Genesis-Ipf-3, the World's First Phase Iii Trial of a Generative AI-Driven Innovative Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2666550995","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666550995?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:30","pubTimestamp":1789000200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA3WSRNY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103728541","title":"AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1103728541","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103728541?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:26","pubTimestamp":1789000007,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced that its lead artificial intelligence-powered investigational drug, Rentosertib (also known as ISM001-055/INS018_055), has achieved a significant clinical milestone...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","IBBQ","NEWZ","AIBU","AIQU","QID","SQQQ","02834","06978","NOCT","CPNQ","07266","CWC","QQA","QQQM","GK","TQQY","09834","09086","QTOC","PBOT","PSQ","QQQX","QMAR","FWD","BK1574","CHAT","QQQ","WPAI","AGIX","DQJN","03455","MDTX","MEDX","OGIG","07261","07568","AQGX","LCLG","QDEC","AIFD","QLD","TECY","KOMP","NBDS","NJAN","03086","IBBJ","MFIG","NAPR","03696","BMED","PSYK","LNGR","TARK","TQQQ","NJUL","07522","ARTY","QSWN","VUSE","159992","161631","MVPS","03034","BK4593","GPIQ","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185231159","title":"Insilico Medicine Marks Milestone as First Patient Dosed in Phase III Trial of AI-Discovered IPF Drug Rentosertib","url":"https://stock-news.laohu8.com/highlight/detail?id=1185231159","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185231159?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:20","pubTimestamp":1788999639,"startTime":"0","endTime":"0","summary":"Insilico Medicine announced the first patient enrollment and dosing in the Phase III GENESIS-IPF-3 study of Rentosertib (ISM001-055/INS018_055), its lead AI-generated small-molecule inhibitor...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142669882","title":"花旗维持英矽智能买入评级，目标价85港元，看好衰老生物学平台潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1142669882","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142669882?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:52","pubTimestamp":1788947533,"startTime":"0","endTime":"0","summary":"花旗发布最新研究报告，基于贴现现金流估值框架，维持对英矽智能（03696）的\"买入/高风险\"评级，目标价定为85港元。该机构同时指出，英矽智能仍是其人工智能药物发现（AIDD）子板块中的首选标的。...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130517989.USD","LU0320765646.SGD","LU1791807156.HKD","BK4207","BK4566","LU2462157665.USD","LU1201861249.SGD","LU1244550221.USD","LU0170899867.USD","LU1144417596.USD","BK4504","TFNS","LU1506573853.SGD","LU0648001328.SGD","IYF","LU1162221912.USD","LU1074936037.SGD","LU2456880835.USD","LU0128525689.USD","LU0477156953.USD","FTXO","LU0980610538.SGD","LU0130102774.USD","BK4534","LU1668664300.SGD","BK4559","LU0162691827.USD","LU2360032135.SGD","BK1141","LU0314106906.USD","LU2417539215.USD","IE00BSNM7G36.USD","03696","LU0106831901.USD","LU0203347892.USD","LU2125154778.USD","LU0052756011.USD","C","BK4588","LU2125154935.USD","LU2236285917.USD","EWH","LU0310800965.SGD","LU1267930227.SGD","LU1366192091.USD","LU1244550494.USD","LU0203345920.USD","BK4585","LU0072461881.USD","LU0098860793.USD","LU1244550577.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105359969","title":"Movement Alert｜INSILICO Rises 6% in Regular Trading, Core Pipeline Rentosertib Published in Nature Biotechnology Showcasing Anti-Aging Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1105359969","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105359969?lang=en_us&edition=fundamental","pubTime":"2026-09-09 09:39","pubTimestamp":1788917985,"startTime":"0","endTime":"0","summary":"On September 9, INSILICO rose 6% in regular trading, trading at 52.75 HKD/share, with turnover of 179 million HKD, extending momentum from the prior session's strong gains.On the news front, the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"INSILICO Surges as Citi Keeps Buy Rating, $85 Target","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117938753","title":"Movement Alert｜INSILICO Rises 5.64% in Regular Trading, Strategic Partnership with MobiDrop to Co-Build AI-Ready Data Infrastructure","url":"https://stock-news.laohu8.com/highlight/detail?id=1117938753","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117938753?lang=en_us&edition=fundamental","pubTime":"2026-09-08 09:32","pubTimestamp":1788831139,"startTime":"0","endTime":"0","summary":"On September 8, INSILICO rose 5.64% in regular trading, trading at HK$51.45 per share, with turnover of HK$72.39 million.On the news front, INSILICO announced on September 7 a strategic partnership...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"INSILICO Gains on MobiDrop AI Data Partnership and Citi Buy","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665313201","title":"Insilico Study Says AI-Designed IPF Drug Rentosertib Reverses Biological Age on Six Proteomic Clocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2665313201","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665313201?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:43","pubTimestamp":1788774199,"startTime":"0","endTime":"0","summary":"Insilico study says AI-designed IPF drug rentosertib reverses biological age on six proteomic clocksInsilico Medicine announced a Nature Biotechnology study analyzing Phase IIa rentosertib data in idi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL97Hymn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665181213","title":"Insilico AI-Developed Drug Candidate Shows Anti-Aging Potential in New Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665181213","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665181213?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:00","pubTimestamp":1788771600,"startTime":"0","endTime":"0","summary":"Tech-bio company Insilico said trial data for an experimental drug to treat an age-related lung disease suggests it could have anti-aging properties, boosting hopes for other emerging therapies discov","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTOC","AIPO","ARTY","VTHR","CHAT","BK1141","03696","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184969761","title":"AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1184969761","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184969761?lang=en_us&edition=fundamental","pubTime":"2026-09-07 07:02","pubTimestamp":1788735760,"startTime":"0","endTime":"0","summary":"The innovative medicine sector is gaining significant momentum as artificial intelligence transforms the drug development landscape from discovery through clinical trials and regulatory approval. A...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","06978","MEDX","BK1593","BK4588","CHAT","AIPO","BK1161","BK1515","VXUS","BK1574","BK4585","ARTY","02228","VTHR","QTOC","BK1617","159992","IBBQ","LNGR","03696","AGIX","BK1191","02196","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108436057","title":"INSILICO Adds 0.25 Million New Shares in August 2026, Keeps Public Float Above 15 %","url":"https://stock-news.laohu8.com/highlight/detail?id=1108436057","media":"Bulletin Express","labels":["SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108436057?lang=en_us&edition=fundamental","pubTime":"2026-09-04 18:41","pubTimestamp":1788518489,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (abbreviated as INSILICO) modestly expanded its share base during August 2026 while confirming full compliance with Hong Kong Stock Exchange (HKEX) public-float...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150283513","title":"InSilico Medicine Cayman TopCo: JPMorgan Chase & Co. Disposes of Shares, Long Position Falls to 5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150283513","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150283513?lang=en_us&edition=fundamental","pubTime":"2026-09-04 17:23","pubTimestamp":1788513828,"startTime":"0","endTime":"0","summary":"On August 31, 2026, JPMorgan Chase & Co. sold 1.25 million shares of InSilico Medicine Cayman TopCo (03696) at an average of HKD 43.5738 per share, involving about HKD 54.69 million.Prior to the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664380772","title":"Hong Kong Stocks Rise on Easing Rate Fears; InSilico Medicine Gains 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664380772","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664380772?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:52","pubTimestamp":1788511941,"startTime":"0","endTime":"0","summary":"Hong Kong stocks closed higher Friday after U.S.  Federal Reserve Governor Christopher Waller's comments eased concerns over another U.S. rate hike, lifting sentiment ahead of U.S. jobs data.The Hang Seng Index gained 437.56 points, or 1.7%, to close at 25,650.87, while the Hang Seng China Enterprises Index rose 169.79 points, or 2%, to 8,555.03.Waller said he would favor keeping interest rates steady if inflation continues to cool, helping boost global markets. Investors also watched developments in China's artificial intelligence sector after Moonshot AI reportedly filed confidentially for a Hong Kong IPO seeking to raise about $3 billion.Baidu  which completed conversion from a secondary listing to a dual primary listing on the Hong Kong Stock Exchange earlier this week rose nearly 5%.In corporate developments, KFM Kingdom  said it was unaware of reasons for unusual share price and trading activity, while its major shareholder KIG Real Estate said it was exploring potential transact","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HHImain","07200","83115","03115","513600","03419","02833","HSI","MCHmain","07500","82800","03696","09115","BK1141","HSTECH","03037","07300","MHImain","02800"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664382186","title":"InSilico Medicine Chairman Earmarks HK$16 Million to Boost Shareholding","url":"https://stock-news.laohu8.com/highlight/detail?id=2664382186","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664382186?lang=en_us&edition=fundamental","pubTime":"2026-09-04 15:33","pubTimestamp":1788507202,"startTime":"0","endTime":"0","summary":"InSilico Medicine  Chairman Aleksandrs Zavoronkovs plans to purchase additional shares of the company this month, allocating up to HK$16 million, according to a Friday bourse filing.Zavoronkovs will purchase the shares in the secondary market using his personal funds, the biotech firm said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664383005","title":"InSilico Medicine Climbs as Chairman Plans to Buy Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2664383005","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664383005?lang=en_us&edition=fundamental","pubTime":"2026-09-04 10:39","pubTimestamp":1788489561,"startTime":"0","endTime":"0","summary":"BUZZ-InSilico Medicine climbs as chairman plans to buy shares** Shares of InSilico Medicine Cayman TopCo3696.HKclimb  7.4% to HK$50.5, their highest level since August 10** Stock set for the biggest one-day pct gain since August 25 in the second rising session** Second biggest pct gainer in Hang Seng Biotech Index.HSBIO, which gains 0.7%** The AI-driven drug discovery and pipeline development group says chairman Aleksandrs Zavoronkovs initiates plan forpurchase of company sharesin the open market using his personal funds, to reflect his confidence in the company's future development prospects** The share purchases will take place during September 2026, with an estimated total amount up to HK$16 million  - co** YTD, stock up 33.9%, benchmark Hang Seng Index.HSIup 0.4%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL1N44W02I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156180851","title":"Movement Alert｜INSILICO Rises 5.32% in Regular Trading, Chairman Launches Up to HK$16 Million Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1156180851","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156180851?lang=en_us&edition=fundamental","pubTime":"2026-09-04 10:07","pubTimestamp":1788487628,"startTime":"0","endTime":"0","summary":"On September 4, INSILICO rose 5.32% in regular trading, trading at HK$49.54/share, with turnover of HK$227 million. The rally was driven by the announcement that Board Chairman, CEO and Chief...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Chairman's HK$16M Buyback Plan Fuels INSILICO Surge","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664680039","title":"Insilico Medicine Cayman Topco's Chairman Initiates Share Increasing Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2664680039","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664680039?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:26","pubTimestamp":1788481609,"startTime":"0","endTime":"0","summary":"BRIEF-Insilico Medicine Cayman Topco's Chairman Initiates Share Increasing PlanSept 4 (Reuters)-Insilico Medicine Cayman TopCo3696.HK:CHAIRMAN ALEKSANDRS ZAVORONKOVS INITIATES SHARE INCREASING PLAN US","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44V157:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142982745","title":"Insilico Medicine: Chairman Plans Up to HKD16.00 Million Share Purchase in September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1142982745","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142982745?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:22","pubTimestamp":1788481337,"startTime":"0","endTime":"0","summary":"Insilico Medicine Cayman TopCo (Insilico Medicine) disclosed that its Chairman, Executive Director, Chief Executive Officer, and Chief Business Officer, Dr. Aleksandrs Zavoronkovs, will initiate an...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143659924","title":"INSILICO Chairman Plans Share Acquisition of Up to HK$16 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1143659924","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143659924?lang=en_us&edition=fundamental","pubTime":"2026-09-04 08:08","pubTimestamp":1788480492,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced that its Board Chairman, Executive Director, Chief Executive Officer, and Chief Commercial Officer, Aleksandrs Zavoronkovs, intends to purchase additional shares of the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}